Tenax Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $1.6M | $13.3M | $12.4M |
| FY2019 | $2.6M | $6.4M | $4.9M |
| FY2020 | $2.2M | $6.9M | $6.3M |
| FY2021 | $1.7M | $6.0M | $5.6M |
| FY2022 | $1.9M | $3.4M | $2.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $1.6M | $13.3M | $12.4M |
| FY2019 | $2.6M | $6.4M | $4.9M |
| FY2020 | $2.2M | $6.9M | $6.3M |
| FY2021 | $1.7M | $6.0M | $5.6M |
| FY2022 | $1.9M | $3.4M | $2.1M |